DOI: 10.1055/s-00000134

Diabetologie und Stoffwechsel

References

Inzucchi SE, Zinman B, Wanner C. et al.
SGLT-2 inhibitors and cardiovascular risk: proposed pathways and review of ongoing outcome trials.

Diab Vasc Dis Res 2015;
12: 90-100

Download Bibliographical Data

Access: